Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression
Antioxidants · 25.03.2026 · 15 (4) · 410
DOI: 10.3390/antiox15040410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 25.03.2026. Verfasst von Sergi Quetglas-Llobera und 4 weiteren Autor:innen. Beteiligte Einrichtung: Grup Multidisciplinari d'Oncologia Translacional, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Bal…. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundació Universitat Empresa de les Illes Balears (FUEIB) - Oficina de Fundraising, Ministerio de Ciencia, Innovación y Universidades, Fundació Universitat Empresa de les Illes Balears (FUEIB)—Oficina de Fundraising.
Abstract (Originalsprache)
Oleocanthal (OC), an anti-inflammatory and antioxidant phenolic compound exclusively found in extra virgin olive oil (EVOO), has emerged as a potential anticancer agent through multiple mechanisms of action, yet its impact on key processes such as cellular metabolism remains insufficiently characterized. Here, we investigated the metabolic and mitochondrial responses to OC across different breast cancer molecular subtypes. Triple-negative (MDA-MB-231) and luminal (MCF7, T47D) breast cancer cell lines were treated with OC to evaluate cell viability, cell cycle progression, metabolic enzyme expression, mitochondrial respiration, and mitochondrial network organization. OC responsiveness differed, being highest in MDA-MB-231 and lowest in T47D cells. Lactate dehydrogenase levels decreased in all cell lines, while mitochondrial response varied. MDA-MB-231 mitochondrial function was fully impaired, while MCF7 cells showed increased respiratory activity, with marked mitochondrial fragmentation, and T47D cells largely preserved mitochondrial integrity and function. Notably, the magnitude of OC effects correlated with MET expression, an established target of OC and a prognostic factor associated with reduced relapse-free survival within the triple-negative subtype. Collectively, these findings identify OC as a modulator of cancer cell metabolism and mitochondrial dynamics, with particular relevance in MET-high triple-negative breast cancers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Grup Multidisciplinari d'Oncologia Translacional, Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), Universitat de les Illes Balears (UIB), 07122 Palma, Spain.
- Institut d'Investigació Sanitària de les Illes Balears (IdISBa), 07010 Palma, Spain.
- Ciber Fisiopatología Obesidad y Nutrición (CB06/03), Instituto Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Sergi Quetglas-Llobera, Pere Miquel Morla-Barcelo, Pilar Roca, Jorge Sastre-Serra, Mercedes Nadal-Serrano
Förderung
- Fundació Universitat Empresa de les Illes Balears (FUEIB) - Oficina de Fundraising
- Ministerio de Ciencia, Innovación y Universidades
- Fundació Universitat Empresa de les Illes Balears (FUEIB)—Oficina de Fundraising
Zitieren
APA
Quetglas-Llobera, S., Morla-Barcelo, P. M., Roca, P., Sastre-Serra, J., & Nadal-Serrano, M. (2026). Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression. Antioxidants, 15(4), 410. https://doi.org/10.3390/antiox15040410
Vancouver
Quetglas-Llobera S, Morla-Barcelo PM, Roca P, Sastre-Serra J, Nadal-Serrano M. Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression. Antioxidants. 2026;15(4):410. doi:10.3390/antiox15040410
BibTeX
@article{QuetglasLlobera2026,
author = {Quetglas-Llobera, Sergi and Morla-Barcelo, Pere Miquel and Roca, Pilar and Sastre-Serra, Jorge and Nadal-Serrano, Mercedes},
title = {Oleocanthal Induces Mitochondrial Dysfunction in Breast Cancer Cell Lines Depending on c-MET Expression},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {4},
pages = {410},
doi = {10.3390/antiox15040410}
}
EUVIMED